In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other therapeutics represents one of the most consequential regulatory developments in ...
Washington, DC—Last month, both the National Institutes of Health and the US Food and Drug Administration announced plans to phase out the use of animals in scientific research. The Animal Welfare ...
Clinical trials are facing a crisis amid growing delays, diminishing success rates and rising costs. Companies across the stakeholder spread are investing in AI to ease some of the longstanding ...
TOLEDO, Ohio, Jan. 8, 2026 /PRNewswire/ -- NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of ...
The Pentagon’s proposed 2026 fiscal year budget comes in at more than one trillion dollars, and $179 billion of that is just for research, development, testing, and evaluation. That money doesn’t go ...
Horses are just as much a part of New Mexico’s story as green chile and balloons. One local startup is hoping their research ...
In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results